Key facts
- This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 16:21.
Birgit Girshick - 31 May 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Corporate Executive VP & COO
- Issuer ticker
- CRL
- Reported as of
- 31 May 2024
- Net transaction value
- +$1,818,014
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 16:21:22 UTC
- Prior SEC filing
- 29 May 2024
- Next SEC filing
- 03 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Birgit Girshick
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 29 May 2024.
- Current net transaction value: +$1,818,014.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +3,838
- Change %
- +8.2%
- Price
- $0.000000
- Shares after
- 50,512
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRL
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $1,818,014
- Shares
- +8,722
- Change %
- Price
- $208.44
- Shares after
- 8,722
- Date
- 31 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,722
- Exercise price
- $208.44
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Unvested restricted stock units vest as follows: 959 on May 31, 2025, 960 on May 31, 2026, 959 on May 31, 2027, and 960 on May 31, 2028.
Footnote F2
Stock options vest as follows: 2,180 on May 31, 2025, 2,181 on May 31, 2026, 2,180 on May 31, 2027, and 2,181 on May 31, 2028.